464 related articles for article (PubMed ID: 3273224)
1. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
2. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755
[TBL] [Abstract][Full Text] [Related]
3. Binding of the Ile-Val and Val-Val effector dipeptides to the binary adducts of bovine trypsinogen with Kunitz and Kazal inhibitors as well as the acylating agent p-nitrophenyl p-guanidinobenzoate. A thermodynamic and kinetic study.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
J Mol Biol; 1987 Apr; 194(4):751-4. PubMed ID: 2443709
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic modeling of internal equilibria involved in the activation of trypsinogen.
Coletta M; Ascenzi P; Bravin L; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Biomol Struct Dyn; 1990 Feb; 7(4):959-72. PubMed ID: 2310525
[TBL] [Abstract][Full Text] [Related]
5. Bovine trypsinogen activation. A thermodynamic study.
Coletta M; Ascenzi P; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
Biophys Chem; 1990 Aug; 37(1-3):355-62. PubMed ID: 2285797
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
[TBL] [Abstract][Full Text] [Related]
7. Activating effect of the Ile-Val dipeptide on the catalytic properties of bovine trypsinogen.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
Biochim Biophys Acta; 1985 Nov; 832(1):1-6. PubMed ID: 4052434
[TBL] [Abstract][Full Text] [Related]
8. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
[TBL] [Abstract][Full Text] [Related]
9. Catalytic and ligand binding properties of bovine trypsinogen and its complex with the effector dipeptide Ile-Val. A comparative study.
Antonini E; Ascenzi P; Bolognesi M; Guarneri M; Menegatti E; Amiconi G
Mol Cell Biochem; 1984; 60(2):163-81. PubMed ID: 6708945
[TBL] [Abstract][Full Text] [Related]
10. Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases.
Hedstrom L; Lin TY; Fast W
Biochemistry; 1996 Apr; 35(14):4515-23. PubMed ID: 8605201
[TBL] [Abstract][Full Text] [Related]
11. Interaction between squash inhibitors and bovine trypsinogen.
Zbyryt T; Otlewski J
Biol Chem Hoppe Seyler; 1991 Apr; 372(4):255-62. PubMed ID: 2059335
[TBL] [Abstract][Full Text] [Related]
12. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
Kaslik G; Westler WM; Gráf L; Markley JL
Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.
Lu D; Fütterer K; Korolev S; Zheng X; Tan K; Waksman G; Sadler JE
J Mol Biol; 1999 Sep; 292(2):361-73. PubMed ID: 10493881
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen exchange kinetics of bovine pancreatic trypsin inhibitor beta-sheet protons in trypsin-bovine pancreatic trypsin inhibitor, trypsinogen-bovine pancreatic trypsin inhibitor, and trypsinogen-isoleucylvaline-bovine pancreatic trypsin inhibitor.
Brandt P; Woodward C
Biochemistry; 1987 Jun; 26(11):3156-67. PubMed ID: 2440473
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
16. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
Popov EM; Godzhaev NM; Aliev RE
Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
18. Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen.
Pasternak A; Liu X; Lin TY; Hedstrom L
Biochemistry; 1998 Nov; 37(46):16201-10. PubMed ID: 9819212
[TBL] [Abstract][Full Text] [Related]
19. Studies on trypsin inhibitors. Part VII. Synthesis of protected peptides related to sequences 1 - 14 and 36 - 52 of porcine pancreatic secretory trypsin inhibitor II (Kazal).
Tomatis R; Guggi A; Salvadori S; Rocchi R
Int J Pept Protein Res; 1977; 9(2):137-47. PubMed ID: 838534
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced changes in the conformational stability of bovine trypsinogen and their implications for the protein function.
Bulaj G; Otlewski J
J Mol Biol; 1995 Apr; 247(4):701-16. PubMed ID: 7723025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
